Table 3.
Age-standardized 5- and 10-year net survival and 95% confidence intervals (95% CI) for breast cancer by age group and sex—Poland, 2000–2019
| Age group | Number of cases | Age-standardized net survival (95% CI) | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 5-year | 10-year | |||||||||
| Men | Women | Men | Women | P-value | CL | Men | Women | P-value | CL | |
| [15–45) | 127 | 36,935 |
80.95% (72.05–87.26%) |
82.70% (82.26–83.12%) |
< 0.001 | 0.98 |
64.21% (52.62–73.66%) |
74.65% (74.09–75.19%) |
< 0.001 | 1.00 |
| [45–55) | 285 | 73,820 |
68.03% (61.34–73.81%) |
83.46% (83.15–83.76%) |
< 0.001 | 1.00 |
55.38% (47.47–62.59%) |
76.68% (76.29–77.06%) |
< 0.001 | 1.00 |
| [55–65) | 654 | 91,051 |
63.86% (59.08–68.24%) |
82.54% (82.23–82.83%) |
< 0.001 | 1.00 |
52.13% (45.92–57.97%) |
75.27% (74.86–75.69%) |
< 0.001 | 1.00 |
| [65–75) | 754 | 66,792 |
65.06% (59.84–69.77%) |
79.37% (78.94–79.78%) |
< 0.001 | 1.00 |
52.24% (44.46–59.45%) |
70.82% (70.17–71.46%) |
< 0.001 | 1.00 |
| [75–99] | 533 | 44,327 |
62.37% (54.02–69.63%) |
67.33% (66.56–68.09%) |
< 0.001 | 1.00 |
38.69% (25.67–51.53%) |
56.81% (55.38–58.22%) |
< 0.001 | 1.00 |